There’s more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

The post Here’s Why Regeneron Pharmaceuticals Just Hit A Record High — Again appeared first on Investor’s Business Daily.